Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Ampio, Ascentage, Asieris, Beigene, Humanigen, Innocare, Merck, Moderna, Sirnaomics, Sorrento.